• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卡罗来纳宫颈癌预防框架的应用。

Application of the Carolina Framework for Cervical Cancer Prevention.

机构信息

Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC, USA.

Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.

出版信息

Gynecol Oncol. 2014 Mar;132 Suppl 1(0 1):S33-40. doi: 10.1016/j.ygyno.2013.12.004. Epub 2013 Dec 10.

DOI:10.1016/j.ygyno.2013.12.004
PMID:24333357
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4020939/
Abstract

OBJECTIVE

The Carolina Framework for Cervical Cancer Prevention describes 4 main causes of cervical cancer incidence: human papillomavirus (HPV) infection, lack of screening, screening errors, and not receiving follow-up care. We present 2 applications of the Carolina Framework in which we identify high-need counties in North Carolina and generate recommendations for improving prevention efforts.

METHODS

We created a cervical cancer prevention need index (CCPNI) that ranked counties on cervical cancer mortality, HPV vaccine initiation and completion, Pap smear screening, and provision of Pap tests to rarely- or never-screened women. In addition, we conducted in-depth interviews with 19 key informants from programs and agencies involved in cervical cancer prevention in North Carolina.

RESULTS

North Carolina's 100 counties varied widely on individual CCPNI components, including annual cervical cancer mortality (median 2.7/100,000 women; range 0.0-8.0), adolescent girls' HPV vaccine initiation (median 42%; range 15%-62%), and Pap testing in the previous 3 years among Medicaid-insured adult women (median 59%; range 40%-83%). Counties with the greatest prevention needs formed 2 distinct clusters in the northeast and south-central regions of the state. Interviews generated 9 recommendations to improve cervical cancer prevention in North Carolina, identifying applications to specific programs and policies in the state.

CONCLUSIONS

This study found striking geographic disparities in cervical cancer prevention need in North Carolina. Future prevention efforts in the state should prioritize high-need regions as well as recommended strategies and applications in existing programs. Other states can use the Carolina Framework to increase the impact of their cervical cancer prevention efforts.

摘要

目的

《卡罗莱纳宫颈癌预防框架》描述了宫颈癌发病率的 4 个主要原因:人乳头瘤病毒(HPV)感染、缺乏筛查、筛查错误以及未接受随访护理。我们介绍了《卡罗莱纳框架》的 2 个应用案例,通过这些案例,我们确定了北卡罗来纳州高需求县,并提出了改善预防工作的建议。

方法

我们创建了一个宫颈癌预防需求指数(CCPNI),根据宫颈癌死亡率、HPV 疫苗接种起始率和完成率、巴氏涂片筛查率以及向很少或从未接受过筛查的女性提供巴氏涂片检查的情况对各县进行排名。此外,我们还对北卡罗来纳州参与宫颈癌预防的 19 名关键信息提供者进行了深入访谈。

结果

北卡罗来纳州的 100 个县在个别 CCPNI 组成部分上差异很大,包括宫颈癌年死亡率(中位数为 2.7/100,000 名女性;范围为 0.0-8.0)、青少年女孩 HPV 疫苗接种起始率(中位数为 42%;范围为 15%-62%)以及过去 3 年 Medicaid 保险成年女性的巴氏涂片检查率(中位数为 59%;范围为 40%-83%)。预防需求最大的县在该州东北部和中南部形成了 2 个不同的集群。访谈提出了 9 项改善北卡罗来纳州宫颈癌预防的建议,确定了州内特定项目和政策的应用。

结论

本研究发现北卡罗来纳州宫颈癌预防需求存在显著的地域差异。该州未来的预防工作应优先考虑高需求地区以及州内现有项目的推荐策略和应用。其他州可以使用《卡罗莱纳框架》来提高其宫颈癌预防工作的效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17fc/4020939/780f61374c9f/nihms574544f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17fc/4020939/780f61374c9f/nihms574544f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17fc/4020939/780f61374c9f/nihms574544f1.jpg

相似文献

1
Application of the Carolina Framework for Cervical Cancer Prevention.卡罗来纳宫颈癌预防框架的应用。
Gynecol Oncol. 2014 Mar;132 Suppl 1(0 1):S33-40. doi: 10.1016/j.ygyno.2013.12.004. Epub 2013 Dec 10.
2
Primary Care Physicians' Adherence to Expert Recommendations for Cervical Cancer Screening and Prevention in the Context of Human Papillomavirus Vaccination.在人乳头瘤病毒疫苗接种背景下,初级保健医生对宫颈癌筛查和预防专家建议的遵循情况。
Sex Transm Dis. 2016 Jul;43(7):438-44. doi: 10.1097/OLQ.0000000000000458.
3
Human papillomavirus vaccine practices in the USA: do primary care providers use sexual history and cervical cancer screening results to make HPV vaccine recommendations?美国的人乳头瘤病毒疫苗接种实践:初级保健提供者是否利用性行为史和宫颈癌筛查结果来推荐 HPV 疫苗?
Sex Transm Infect. 2012 Oct;88(6):433-5. doi: 10.1136/sextrans-2011-050437. Epub 2012 Apr 21.
4
Economic evaluation of policy options for prevention and control of cervical cancer in Thailand.泰国宫颈癌预防和控制政策选择的经济评价。
Pharmacoeconomics. 2011 Sep;29(9):781-806. doi: 10.2165/11586560-000000000-00000.
5
Human Papillomavirus Vaccination and Pap Smear Uptake Among Young Women in the United States: Role of Provider and Patient.美国年轻女性的人乳头瘤病毒疫苗接种与巴氏涂片检查情况:医疗服务提供者与患者的作用
J Womens Health (Larchmt). 2017 Oct;26(10):1114-1122. doi: 10.1089/jwh.2017.6424. Epub 2017 Aug 25.
6
U.S. geographic distribution of prevaccine era cervical cancer screening, incidence, stage, and mortality.美国疫苗时代前宫颈癌筛查、发病、分期和死亡率的地域分布。
Cancer Epidemiol Biomarkers Prev. 2011 Apr;20(4):591-9. doi: 10.1158/1055-9965.EPI-10-1183. Epub 2011 Jan 25.
7
Impact of pap test compliance and cervical cancer screening intervals on human papillomavirus vaccine acceptance.巴氏涂片检查依从性和宫颈癌筛查间隔对人乳头瘤病毒疫苗接种接受度的影响。
J Low Genit Tract Dis. 2012 Jan;16(1):39-44. doi: 10.1097/LGT.0b013e31822e8e25.
8
Persistent Disparities in Cervical Cancer Screening Uptake: Knowledge and Sociodemographic Determinants of Papanicolaou and Human Papillomavirus Testing Among Women in the United States.持续性的宫颈癌筛查参与率差距:美国女性巴氏涂片检查和人乳头瘤病毒检测的知识与社会人口学决定因素。
Public Health Rep. 2020 Jul/Aug;135(4):483-491. doi: 10.1177/0033354920925094. Epub 2020 Jun 9.
9
Preference for Human Papillomavirus Self-Collection and Papanicolaou: Survey of Underscreened Women in North Carolina.偏好人乳头瘤病毒自我采集和巴氏涂片:北卡罗来纳州未筛查女性的调查。
J Low Genit Tract Dis. 2018 Oct;22(4):302-310. doi: 10.1097/LGT.0000000000000430.
10
Knowledge, attitudes, and practices toward cervical cancer prevention among women in Kampong Speu Province, Cambodia.柬埔寨磅湛省女性对宫颈癌预防的知识、态度和实践。
BMC Cancer. 2018 Mar 15;18(1):294. doi: 10.1186/s12885-018-4198-8.

引用本文的文献

1
Exploratory Analysis of Concordance Between Clinician-Collected and Self-Sampled Human Papillomavirus Tests in a Small Cohort of Average- and High-Risk Patients.在一小群中低风险和高风险患者中,临床医生采集与人乳头瘤病毒自检样本检测结果一致性的探索性分析
Womens Health Rep (New Rochelle). 2024 Mar 13;5(1):259-266. doi: 10.1089/whr.2024.0004. eCollection 2024.
2
County-level characteristics associated with incidence, late-stage incidence, and mortality from screenable cancers.与可筛查癌症的发病率、晚期发病率和死亡率相关的县级特征。
Cancer Epidemiol. 2021 Dec;75:102033. doi: 10.1016/j.canep.2021.102033. Epub 2021 Sep 21.
3

本文引用的文献

1
A systematic evaluation of different methods for calculating adolescent vaccination levels using immunization information system data.使用免疫信息系统数据评估不同方法计算青少年疫苗接种率的系统评价。
Public Health Rep. 2013 Nov-Dec;128(6):489-97. doi: 10.1177/003335491312800608.
2
Role and uptake of human papillomavirus vaccine in adolescent health in the United States.人乳头瘤病毒疫苗在美国青少年健康中的作用及接种情况
Adolesc Health Med Ther. 2011 Aug;2011(2):63-74. doi: 10.2147/AHMT.S15941.
3
National and state vaccination coverage among adolescents aged 13-17 years--United States, 2012.
Predictors of Cervical Cancer Screening Among Infrequently Screened Women Completing Human Papillomavirus Self-Collection: My Body My Test-1.
HPV 自我采样后未定期筛查女性的宫颈癌筛查预测因素:我的身体我的检测-1。
J Womens Health (Larchmt). 2019 Aug;28(8):1094-1104. doi: 10.1089/jwh.2018.7141. Epub 2019 Mar 15.
4
Impact of Pharmacists on Access to Vaccine Providers: A Geospatial Analysis.药剂师对疫苗接种服务获取的影响:一项地理空间分析。
Milbank Q. 2018 Sep;96(3):568-592. doi: 10.1111/1468-0009.12342.
5
Knowledge of cervical cancer, human papillomavirus and prevention among first-year female students in residences at the University of the Free State.自由州大学住宿的一年级女学生对宫颈癌、人乳头瘤病毒及预防的了解情况。
Afr J Prim Health Care Fam Med. 2018 May 24;10(1):e1-e5. doi: 10.4102/phcfm.v10i1.1637.
全国和各州青少年(13-17 岁)疫苗接种覆盖率——美国,2012 年。
MMWR Morb Mortal Wkly Rep. 2013 Aug 30;62(34):685-93.
4
Human papillomavirus vaccination coverage among adolescent girls, 2007-2012, and postlicensure vaccine safety monitoring, 2006-2013 - United States.2007-2012 年美国少女接种人乳头瘤病毒疫苗的情况,以及 2006-2013 年疫苗上市后的安全性监测。
MMWR Morb Mortal Wkly Rep. 2013 Jul 26;62(29):591-5.
5
Social equity in Human Papillomavirus vaccination: a natural experiment in Calgary Canada.人乳头瘤病毒疫苗接种中的社会公平性:加拿大卡尔加里的自然实验。
BMC Public Health. 2013 Jul 9;13:640. doi: 10.1186/1471-2458-13-640.
6
Recommendations for a national agenda to substantially reduce cervical cancer.关于大幅减少宫颈癌的国家议程的建议。
Cancer Causes Control. 2013 Aug;24(8):1583-93. doi: 10.1007/s10552-013-0235-8. Epub 2013 Jul 5.
7
Longitudinal predictors of human papillomavirus vaccination among a national sample of adolescent males.全国青少年男性样本中人类乳头瘤病毒疫苗接种的纵向预测因素。
Am J Public Health. 2013 Aug;103(8):1419-27. doi: 10.2105/AJPH.2012.301189. Epub 2013 Jun 13.
8
Beliefs, behaviors and HPV vaccine: correcting the myths and the misinformation.信念、行为与 HPV 疫苗:纠正误区与误解。
Prev Med. 2013 Nov;57(5):414-8. doi: 10.1016/j.ypmed.2013.05.013. Epub 2013 May 31.
9
Screening for cervical cancer: a systematic review and meta-analysis.宫颈癌筛查:系统评价和荟萃分析。
Syst Rev. 2013 May 24;2:35. doi: 10.1186/2046-4053-2-35.
10
The Patient Protection and Affordable Care Act: impact on the care of gynecologic oncology patients in the absence of Medicaid expansion in central Virginia.《患者保护与平价医疗法案》:弗吉尼亚州中部在不扩大医疗补助计划的情况下对妇科肿瘤患者护理的影响。
Gynecol Oncol. 2013 Aug;130(2):346-9. doi: 10.1016/j.ygyno.2013.04.468. Epub 2013 May 3.